Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2016 | Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis | I-CHUN CHEN ; CHING-HUNG LIN ; I-SHIOW JAN ; ANN-LII CHENG ; YEN-SHEN LU | Journal of the Formosan Medical Association | 18 | 11 | |
2014 | Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers | HSIANG-FONG KAO ; I-CHUN CHEN ; CHIUN HSU ; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN ; Hu F.-C.; CHIH-HSIN YANG ; ANN-LII CHENG ; KUN-HUEI YEH | Supportive Care in Cancer | 10 | 10 | |
2016 | Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer | I-CHUN CHEN ; Chang Y.-C.; YEN-SHEN LU ; KUEI-PIN CHUNG ; CHIUN-SHENG HUANG ; TZU-PIN LU ; WEN-HUNG KUO ; Wang M.-Y.; KUAN-TING KUO ; Wu P.-F.; Hsueh T.-H.; Shen C.-Y.; CHING-HUNG LIN ; ANN-LII CHENG | Scientific Reports | 18 | 17 | |
2022 | Develop companion radiopharmaceutical YKL40 antibodies as potential theranostic agents for epithelial ovarian cancer | Chang, Ming-Cheng; Chiang, Ping-Fang; Kuo, Yu-Jen; Peng, Cheng-Liang; I-CHUN CHEN ; Huang, Chia-Yen; CHI-AN CHEN ; YING-CHENG CHIANG | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2 | 1 | |
2023 | Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysis | Peng, Shang-Hsuan; CHING-HUNG LIN ; I-CHUN CHEN ; YING-CHUN SHEN ; DWANG-YING CHANG ; WEI-WU CHEN ; Huang, Shu-Min; Hu, Fu-Chang; YEN-SHEN LU | Cancer medicine | 0 | 0 | |
2020 | Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations | Chen C.-H.; YEN-SHEN LU ; ANN-LII CHENG ; CHIUN-SHENG HUANG ; WEN-HUNG KUO ; Wang M.-Y.; Chao M.; I-CHUN CHEN ; Kuo C.-W.; TZU-PIN LU ; CHING-HUNG LIN | Oncologist | 32 | 32 | |
2023 | Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women | CHING-HUNG LIN ; Zahid, Muhammad; WEN-HUNG KUO ; Hu, Fu-Chang; MING-YANG WANG ; I-CHUN CHEN ; Beseler, Cheryl L; Mondal, Bodhisattwa; YEN-SHEN LU ; Rogan, Eleanor G; ANN-LII CHENG | Cancer prevention research (Philadelphia, Pa.) | 0 | 0 | |
2021 | High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia | LIN, CHING-HUNG ; RUBY YUN-JU HUANG ; TZU-PIN LU ; KUAN-TING KUO ; Lo, Ko-Yun; Chen, Ching-Hsuan; I-CHUN CHEN ; YEN-SHEN LU ; ERIC YAO-YU CHUANG ; Thiery, Jean Paul; CHIUN-SHENG HUANG ; ANN-LII CHENG | NPJ breast cancer | 4 | 4 | |
2015 | High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country | CHING-HUNG LIN ; Shen C.-Y.; JIH-HSIANG LEE ; CHIUN-SHENG HUANG ; CHIH-HSIN YANG ; WEN-HUNG KUO ; DWANG-YING CHANG ; Hsiung C.-N.; KUAN-TING KUO ; WEI-WU CHEN ; I-CHUN CHEN ; Wu P.-F.; SUNG-HSIN KUO ; Chen C.-J.; YEN-SHEN LU ; ANN-LII CHENG | PLoS ONE | 10 | 6 | |
2022 | High-Fat Diet-Induced Obesity Alters Dendritic Cell Homeostasis by Enhancing Mitochondrial Fatty Acid Oxidation | I-CHUN CHEN ; Awasthi, Deepika; Hsu, Chia-Lang; Song, Minkyung; Chae, Chang-Suk; Dannenberg, Andrew J; Cubillos-Ruiz, Juan R | Journal of immunology (Baltimore, Md. : 1950) | 11 | 9 | |
2011 | Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era | I-CHUN CHEN ; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; HUANG-CHUN LIEN ; CHIUN HSU ; WEN-HUNG KUO ; YEN-SHEN LU ; ANN-LII CHENG | Breast Cancer Research and Treatment | 87 | 74 | |
2018 | Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link | Zahid H.; Subbaramaiah K.; Iyengar N.M.; Zhou X.K.; I-CHUN CHEN ; Bhardwaj P.; Gucalp A.; Morrow M.; Hudis C.A.; Dannenberg A.J.; Brown K.A. | International Journal of Obesity | 51 | 44 | |
2023 | Lifestyle Factors and Energy Intakes with Risks of Breast Cancer among Pre- and Post- Menopausal Women in Taiwan | Huang, Meng-Chuan; Huang, Tz-Ting; Feng, Hsin-Chun; I-CHUN CHEN ; Chang, Chiao-I; Wang, Tsu-Nai; WEN-HUNG KUO ; Wang, Ming-Yang; LI-WEI TSAI ; Li, Szu-Yi; Huang, Chiun-Sheng; YEN-SHEN LU ; CHING-HUNG LIN | Nutrients | 1 | | |
2018 | National survey of ABC (A1C, blood pressure, cholesterol) of Diabetes Health Promotion Institutes in Taiwan: 2002–2018 | CHIH-YUAN WANG ; Tu, Shih-Te; Sheu, Wayne H-H; I-CHUN CHEN ; LEE-MING CHUANG ; MING-SHIANG WU ; CHONG-JEN YU | Journal of the Formosan Medical Association = Taiwan yi zhi | 14 | 10 | |
2017 | Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF | Quail D.F.; Olson O.C.; Bhardwaj P.; Walsh L.A.; Akkari L.; Quick M.L.; I-CHUN CHEN ; Wendel N.; Ben-Chetrit N.; Walker J.; Holt P.R.; Dannenberg A.J.; Joyce J.A. | Nature Cell Biology | 181 | 164 | |
2020 | The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice | Gonzalez-Ericsson P.I.; Stovgaard E.S.; Sua L.F.; Reisenbichler E.; Kos Z.; Carter J.M.; Michiels S.; Le Quesne J.; Nielsen T.O.; Lænkholm A.-V.; Fox S.B.; Adam J.; Bartlett J.M.S.; Rimm D.L.; Quinn C.; Peeters D.; Dieci M.V.; Vincent-Salomon A.; Cree I.; Hida A.I.; Balko J.M.; Haynes H.R.; Frahm I.; Acosta-Haab G.; Balancin M.; Bellolio E.; Yang W.; Kirtani P.; Sugie T.; Ehinger A.; Castaneda C.A.; Kok M.; McArthur H.; Siziopikou K.; Badve S.; Fineberg S.; Gown A.; Viale G.; Schnitt S.J.; Pruneri G.; Penault-Llorca F.; Hewitt S.; Thompson E.A.; Allison K.H.; Symmans W.F.; Bellizzi A.M.; Brogi E.; Moore D.A.; Larsimont D.; Dillon D.A.; Lazar A.; HUANG-CHUN LIEN ; Goetz M.P.; Broeckx G.; El Bairi K.; Harbeck N.; Cimino-Mathews A.; Sotiriou C.; Adams S.; Liu S.-W.; Loibl S.; I-CHUN CHEN ; Lakhani S.R.; Juco J.W.; Denkert C.; Blackley E.F.; Demaria S.; Leon-Ferre R.; Gluz O.; Zardavas D.; Emancipator K.; Ely S.; Loi S.; Salgado R.; Sanders M. | Journal of Pathology | 134 | 114 | |
2017 | Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen | I-CHUN CHEN ; Hsiao L.-P.; Huang I.-W.; Yu H.-C.; Yeh L.-C.; CHING-HUNG LIN ; Wei-Wu Chen T.; ANN-LII CHENG ; YEN-SHEN LU | Scientific Reports | 23 | 20 | |
2019 | PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study | MING-HAN YANG ; I-CHUN CHEN ; YEN-SHEN LU | Journal of the Formosan Medical Association | 21 | 17 | |
2020 | Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer | Kos Z.; Roblin E.; Kim R.S.; Michiels S.; Gallas B.D.; Chen W.; van de Vijver K.K.; Goel S.; Adams S.; Demaria S.; Viale G.; Moreira A.M.; Richardson A.; Vingiani A.; Bellizzi A.M.; Guerrero A.; Grigoriadis A.; Garrido-Castro A.C.; Cimino-Mathews A.; Srinivasan A.; Acs B.; Nielsen T.O.; Singh B.; Calhoun B.; Haibe-Kans B.; Solomon B.; Thapa B.; Nelson B.H.; Ballesteroes-Merino C.; Criscitiello C.; Boeckx C.; Colpaert C.; Badve S.S.; Quinn C.; Chennubhotla C.S.; Solinas C.; Drubay D.; Sabanathan D.; Peeters D.; Zardavas D.; Höflmayer D.; Johnson D.B.; Thompson E.A.; Symmans W.F.; Perez E.; ElGabry E.A.; Blackley E.F.; Reisenbichler E.; Chmielik E.; Gaire F.; Lu F.-I.; Azmoudeh-Ardalan F.; Peale F.; Hirsch F.R.; Sotiriou C.; Acosta-Haab G.; Farshid G.; Broeckx G.; Koeppen H.; Haynes H.R.; McArthur H.; Joensuu H.; Olofsson H.; Cree I.; Nederlof I.; Rimm D.L.; Frahm I.; Brcic I.; Chan J.; Ziai J.; Brock J.; Weseling J.; Giltnane J.; Lemonnier J.; Zha J.; Ribeiro J.; Hewitt S.; Lennerz J.K.; Carter J.M.; Hartman J.; Hainfellner J.; Le Quesne J.; Juco J.W.; van den Berg J.; Sanchez J.; Cucherousset J.; Adam J.; Denkert C.; Balko J.M.; Saeger K.; Siziopikou K.; Sikorska K.; Weber K.; Steele K.E.; Emancipator K.; El Bairi K.; Allison K.H.; Korski K.; Loibl S.; Buisseret L.; Shi L.; Kooreman L.F.S.; Molinero L.; Estrada M.V.; Van Seijen M.; Lacroix-Triki M.; Sebastian M.M.; Balancin M.L.; Mathieu M.-C.; Luen S.J.; van de Vijver M.; Rebelatto M.C.; Piccart M.; Goetz M.P.; Preusser M.; Khojasteh M.; Sanders M.E.; Regan M.M.; Barnes M.; Christie M.; Bartlett J.M.S.; Misialek M.; Ignatiadis M.; de Maaker M.; Van Bockstal M.; Harbeck N.; Tung N.; Laudus N.; Sirtaine N.; Burchardi N.; Ternes N.; Savas P.; Radosevic-Robin N.; Gluz O.; Grimm O.; Nuciforo P.; Jank P.; Kirtani P.; Watson P.H.; Jelinic P.; Francis P.A.; Russell P.A.; Pruneri G.; Pierce R.H.; Hills R.; Leon-Ferre R.; de Wind R.; Shui R.; Leung S.; Tabbarah S.; Souza S.C.; O’Toole S.; Swain S.; Dillon D.A.; Dudgeon S.; Willis S.; Ely S.; Bedri S.; Irshad S.; Liu S.; Hendry S.; Bianchi S.; Bragança S.; Paik S.; Cheang M.C.U.; Luz S.; Gevaert T.; d’Alfons T.; John T.; Sugie T.; Kurkure U.; Bossuyt V.; Manem V.; Cámaea V.P.; Tong W.; Tutt A.; Tran W.T.; Wang Y.; Allory Y.; Husain Z.; Bago-Horvath Z.; the International Immuno-Oncology Biomarker Working Group; Hall J.A.; Kok M.; Horlings H.M.; Madabhushi A.; van der Laak J.; Ciompi F.; Laenkholm A.-V.; Bellolio E.; Gruosso T.; Fox S.B.; Araya J.C.; Floris G.; Hudeček J.; Voorwerk L.; Beck A.H.; Kerner J.; Larsimont D.; Declercq S.; Van den Eynden G.; Pusztai L.; Ehinger A.; Yang W.; AbdulJabbar K.; Yuan Y.; Singh R.; Hiley C.; Bakir M.; Lazar A.J.; Naber S.; Wienert S.; Castillo M.; Curigliano G.; Dieci M.-V.; André F.; Swanton C.; Reis-Filho J.; Sparano J.; Balslev E.; I-CHUN CHEN ; Stovgaard E.I.S.; Pogue-Geile K.; Blenman K.R.M.; Penault-Llorca F.; Schnitt S.; Lakhani S.R.; Vincent-Salomon A.; Rojo F.; Braybrooke J.P.; Hanna M.G.; Soler-Monsó M.T.; Bethmann D.; Castaneda C.A.; Willard-Gallo K.; Sharma A.; HUANG-CHUN LIEN ; Fineberg S.; Thagaard J.; Comerma L.; Gonzalez-Ericsson P.; Brogi E.; Loi S.; Saltz J.; Klaushen F.; Cooper L.; Amgad M.; Moore D.A.; Salgado R.; Hyytiäinen A.; Hida A.I.; Thompson A.; Lefevre A.; Gown A.; Lo A.; Sapino A. | npj Breast Cancer | 87 | 90 | |
2023 | Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer | WEI-WU CHEN ; Hsiao, Wen; Dai, Ming-Shen; CHING-HUNG LIN ; DWANG-YING CHANG ; I-CHUN CHEN ; MING-YANG WANG ; Chang, Shu-Han; Huang, Shu-Min; ANN-LII CHENG ; Wu, Ko-Wen; Tan, Kien Thiam; YEN-SHEN LU | Breast cancer research and treatment | 0 | 0 | |